DT&CRO CO., Ltd. (KOSDAQ:383930)
3,360.00
+105.00 (3.23%)
At close: Apr 2, 2026
DT&CRO CO. Company Description
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea.
The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting.
DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.
DT&CRO CO., Ltd.
| Country | South Korea |
| Founded | 2017 |
| Industry | Commercial Physical and Biological Research |
Contact Details
Address: 28, Baengnyeong-ro 20beon-gil Yongin-si, 17042 South Korea | |
| Phone | 82 3 1322 2400 |
| Website | dtncro.com |
Stock Details
| Ticker Symbol | 383930 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |